Phillips Medisize acquires Chippenham facility to expand inhalation center of excellence

Phillips Medisize, a Molex company, announced an investment to acquire the complete footprint of its Chippenham site (58,963 square meters) to strengthen its Global Inhalation Center of Excellence, providing additional capacity for drug-device combination product development and manufacturing.

“Phillips Medisize, a Molex company and a leader in the design, development, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, today announced an investment to acquire the complete footprint of its Chippenham site.”businesswire.com

• 1 source
• businesswire.comPhillips Medisize Acquires Chippenham Facility to Expand Global Inhalation Center of ExcellenceMedia ContactNov 5, 2026

Summarized from public sources; check the original articles before acting on it.